The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorth Atl.smlr Regulatory News (NAS)

Share Price Information for North Atl.smlr (NAS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,240.00
Bid: 4,200.00
Ask: 4,300.00
Change: 80.00 (1.92%)
Spread: 100.00 (2.381%)
Open: 4,120.00
High: 4,240.00
Low: 4,120.00
Prev. Close: 4,160.00
NAS Live PriceLast checked at -
North Atlantic Smaller Companies is an Investment Trust

To provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

17 Dec 2013 09:08

RNS Number : 7238V
North Atlantic Smlr Co Inv Tst PLC
17 December 2013
 



NORTH ATLANTIC SMALLER COMPANIES INVESTMENT TRUST PLC

 

INTERIM MANAGEMENT STATEMENT FOR THE PERIOD ENDED 31 OCTOBER 2013

 

To the members of North Atlantic Smaller Companies Investment Trust PLC

This interim management statement has been produced solely to provide additional information to shareholders as a body in accordance with the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.

 

This interim management statement relates to the period from 1 August 2013 to 31 October 2013, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified.

 

Investment Objective

The objective of North Atlantic Smaller Companies Investment Trust PLC ("the Company") is to provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

 

Financial Highlights

Cumulative performance

As at

31 October 2013

3 months %

6 months %

1 year 

%

3 years %

5 years %

Diluted NAV*

1,864p 

2.2 

8.4 

25.7

36.7 

84.9 

Mid-market price

1,588p 

6.4 

13.8 

38.0

52.0 

146.2 

Discount to diluted NAV *

14.8% 

Standard & Poor's 500 Composite Index **

1,095.1 

(1.2)

6.5 

25.1

48.4 

81.7 

Russell 2000 **

685.9 

(0.2)

12.4 

35.1

56.4 

105.1 

FTSE All-Share Index

3,585.3 

2.2 

5.8 

18.6

22.1 

64.2 

US Dollar/Sterling exchange rate

1.6066 

(6.0)

(3.2)

0.3

(0.5)

0.6 

 

* Following the conversion of the Loan Notes the performance is shown on the diluted NAV, excluding retained revenue for the period, only. The Board considers that this accurately reflects the underlying performance of the Company

** Sterling adjusted.

 

 

Material Events and Transactions during the Period

 

During the period under review, the Company's holdings in Bionostics and Orthoproducts were sold at a good uplift to the year-end valuation and at a significant premium to cost. As a result, the Company now has cash or near cash balances of circa £80 million.

 

 

Transactions in Own Shares

 

On 26 September 2013, 1,450 Ordinary shares were bought back for cancellation, at a total cost to the Company of £22,000.

 

Since 31 October 2013, a further 13,483 Ordinary shares were bought back for cancellation, in two tranches, at the beginning of December 2013, at a total cost of £208,000.

 

Following these purchases the Company's issued share capital consists of 15,897,501 Ordinary shares.

 

 

 

TEN LARGEST INVESTMENTS AT 31 OCTOBER 2013

Gleeson (MJ) Group

UK Listed

11.5

US Treasury Bills

US Treasury Bills

18.8

Oryx International Growth Fund Limited *

UK Listed

11.5

Trident Private Equity Fund III LLP

UK Unquoted

8.3

Hampton Investment Properties Limited

UK Unquoted

5.2

Bioquell

UK Listed

4.7

Guinness Peat Group **

UK Listed

4.5

Celsis AG

US Unquoted

3.5

AssetCo PLC

UK Listed

2.8

Goals Soccer Centres

UK Listed

2.6

% of total portfolio

73.4

 

* incorporated in Guernsey

** incorporated in New Zealand

 

SECTOR ANALYSIS OF INVESTMENTS AT FAIR VALUE AS AT 31 OCTOBER 2013

 

United 

United 

Total 

States 

Kingdom 

Europe 

Investment Companies

20.5

20.5

Treasury Bills

18.8

18.8

Construction & Materials

11.5

11.5

Real Estate

0.2

7.6

0.4

8.2

Support Services

1.0

5.1

6.1

Industrial Engineering

5.1

5.1

Health Care, Equipment & Services

0.2

4.7

4.9

Financial Services

4.5

4.5

Travel & Leisure

3.5

3.5

Media

3.2

3.2

Banks

3.1

3.1

Escrows

1.7

0.4

2.1

Oil & Gas Producers

1.2

0.8

2.0

General Retailers

1.7

1.7

Technology Hardware & Equipment

1.5

1.5

Food Producers

1.3

1.3

Industrial Transportation

1.3

1.3

Business Services

0.7

0.7

 

The financial information for the period ended 31 October 2013 contained within this Interim Management Statement has not been audited.

 

 

By order of the Board

 

 

Bonita Guntrip

Company Secretary

17 December 2013

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGMMMZLNDGFZG
Date   Source Headline
12th Jul 201911:58 amRNSDirector/PDMR Shareholding
11th Jul 20193:13 pmRNSNet Asset Value(s)
4th Jul 20192:59 pmRNSHolding(s) in Company
4th Jul 20192:14 pmRNSHolding(s) in Company
28th Jun 201912:13 pmRNSHolding(s) in Company
25th Jun 20194:17 pmRNSAGM Statement
17th Jun 20195:30 pmRNSNet Asset Value(s)
31st May 20193:14 pmRNSDividend Declaration
28th May 20194:58 pmRNSAnnual Financial Report
20th May 20196:24 pmRNSFinal Results
13th May 20192:12 pmRNSNet Asset Value(s)
2nd May 20197:00 amRNSStatement re Related Party Transaction
12th Apr 201910:06 amRNSNet Asset Value(s)
28th Mar 20194:41 pmRNSNet Asset Value(s)
18th Feb 20194:04 pmRNSHolding(s) in Company
15th Feb 20193:33 pmRNSNotification of Major Holdings
15th Feb 201910:50 amRNSNet Asset Value(s)
14th Feb 20195:13 pmRNSHolding(s) in Company
8th Feb 20194:25 pmRNSHolding(s) in Company
15th Jan 20192:27 pmRNSHolding(s) in Company
14th Jan 201910:37 amRNSNet Asset Value(s)
11th Jan 201911:54 amRNSHolding(s) in Company
14th Dec 20184:35 pmRNSNet Asset Value(s)
12th Dec 201811:01 amRNSHolding(s) in Company
5th Dec 20182:15 pmRNSHolding(s) in Company
14th Nov 201810:53 amRNSNet Asset Value(s)
5th Nov 20184:47 pmRNSHolding(s) in Company
31st Oct 20184:17 pmRNSHolding(s) in Company
12th Oct 20189:59 amRNSNet Asset Value(s)
18th Sep 20189:23 amRNSTransaction in Own Shares
14th Sep 20182:30 pmRNSNet Asset Value(s)
13th Sep 20189:44 amRNSHalf-year Report
13th Aug 201812:19 pmRNSNet Asset Value(s)
11th Jul 201812:34 pmRNSNet Asset Value(s)
29th Jun 201811:08 amRNSDirectorate Change
26th Jun 20182:50 pmRNSResult of AGM
13th Jun 20184:35 pmRNSHolding(s) in Company
11th Jun 201810:49 amRNSNet Asset Value(s)
23rd May 201810:19 amRNSAnnual Financial Report
14th May 201812:34 pmRNSNet Asset Value(s)
11th May 20184:56 pmRNSFinal Results
27th Apr 201810:15 amRNSHolding(s) in Company
18th Apr 20182:38 pmRNSHolding(s) in Company
11th Apr 201810:47 amRNSNet Asset Value(s)
15th Mar 20184:28 pmRNSNet Asset Value(s)
15th Feb 20183:02 pmRNSDirector/PDMR Shareholding
12th Feb 201811:28 amRNSNet Asset Value(s)
24th Jan 201812:08 pmRNSHolding(s) in Company
22nd Jan 201810:35 amRNSHolding(s) in Company
16th Jan 201810:29 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.